-
1.发明授权Treatment of acute ischemic stroke or intracranial bleeding with tPa and carbamylated erythropoietin 有权用tPa和氨基甲酰化促红细胞生成素治疗急性缺血性卒中或颅内出血公开(公告)号：US08987190B2
公开(公告)日：2015-03-24
申请号：US13510560
申请日：2010-11-15
CPC分类号： A61K38/482 , A61K38/1816 , A61K38/49 , A61K2300/00
摘要： The present invention relates a method for the treatment of intracranial bleeding comprising administration of a therapeutically effective amount of tPa and a therapeutically effective amount of carbamylated erythropoietin.
摘要翻译： 本发明涉及治疗颅内出血的方法，包括施用治疗有效量的tPa和治疗有效量的氨基甲酰化促红细胞生成素。
-
2.发明申请Treatment of Acute Ischemic Stroke or Intracranial Bleeding with tPA and Carbamylated Erythropoietin 有权用tPA和羧甲基化红细胞生成素治疗急性缺血性卒中或颅内出血公开(公告)号：US20130259853A1
公开(公告)日：2013-10-03
申请号：US13510560
申请日：2010-11-15
CPC分类号： A61K38/482 , A61K38/1816 , A61K38/49 , A61K2300/00
摘要： The present invention relates a method for the treatment of intracranial bleeding comprising administration of a therapeutically effective amount of tPa and a therapeutically effective amount of carbamylated erythropoietin.
摘要翻译： 本发明涉及治疗颅内出血的方法，包括施用治疗有效量的tPa和治疗有效量的氨基甲酰化促红细胞生成素。
-
![METHODS OF ADMINISTERING (4AR,10AR)-1-N-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO [G] QUINOLINE-6,7-DIOL AND RELATED COMPOUNDS ACROSS THE ORAL MUCOSA, THE NASAL MUCOSA OR THE SKIN AND PHARMACEUTICAL COMPOSITIONS THEREOF](/abs-image/US/2012/03/29/US20120077836A1/abs.jpg.150x150.jpg)
3.发明申请METHODS OF ADMINISTERING (4AR,10AR)-1-N-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO [G] QUINOLINE-6,7-DIOL AND RELATED COMPOUNDS ACROSS THE ORAL MUCOSA, THE NASAL MUCOSA OR THE SKIN AND PHARMACEUTICAL COMPOSITIONS THEREOF 审中-公开（4AR，10AR）-1-N-PROPLL-1,2,3,4,4A，5,10,10A-OCTAHYDROBENZO [G]喹啉-7,7-二醇及其相关化合物的方法通过口服粘蛋白， NASAL MUCOSA或其皮肤和药物组合物公开(公告)号：US20120077836A1
公开(公告)日：2012-03-29
申请号：US13202590
申请日：2010-02-26
申请人： Håkan Wikström , Morten Jorgensen , Niels Mork , Jennifer Larsen , Benny Bang-Andersen , Thomas Nikolaj Sager , Ask Püschl , Lars Torup
发明人： Håkan Wikström , Morten Jorgensen , Niels Mork , Jennifer Larsen , Benny Bang-Andersen , Thomas Nikolaj Sager , Ask Püschl , Lars Torup
IPC分类号： A61K31/473 , A61P25/16
CPC分类号： A61K31/473 , A61K9/0019 , A61K9/0056 , A61K9/006
摘要： Disclosed are pharmaceutical compositions and methods for the administration of (4aR,10aR)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoline-6,7-diol or a pharmaceutically acceptable salt thereof and related compounds for the treatment of neurological disorder such as Parkinson's disease and restless leg syndrome.
摘要翻译： 公开了用于（4aR，10aR）-1-正丙基-1,2,3,4,4a，5,10,10a-八氢 - 苯并[g]喹啉-6,7-二酮的药物组合物和方法， 二醇或其药学上可接受的盐和用于治疗神经障碍的相关化合物，例如帕金森病和不宁腿综合征。
-
-
搜索结果
3 条记录 (耗时 0.018 秒)
